New York, United States , July 25, 2024 (GLOBE NEWSWIRE) -- The Global Musculoskeletal Market Size is Expected to Hold a Significant Share by 2033, at a Compound Annual Growth Rate (CAGR) of 6.2% during the projected period.
Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/5099
Musculoskeletal disorders are injuries or illnesses affecting the human musculoskeletal system. The injured or impacted areas are the muscles, ligaments, nerves, tendons, spinal discs, and cartilage. The most common musculoskeletal disorders are rheumatoid arthritis, osteoporosis, gout, osteoarthritis, and back discomfort. Musculoskeletal pain results from normal activities' wear and tear on muscle tissue. WHO studies estimated that 1.71 billion persons worldwide are afflicted with musculoskeletal ailments. The most modern techniques—such as biologics, small molecules, stem cell research, and others help to increase the precision of medication and therapy. Techniques such as organ-on-a-chip, lab-on-a-chip, gene therapy, and orthobiologics have enhanced treatment options for musculoskeletal issues. In addition, treatments such as bone grafting help to mend fractured bones. Thus, it is expected that significant research and development as well as improved care offerings will contribute to market expansion. However, the high cost of care promotes unnecessary MSD care, which limits root-cause treatment.
Browse key industry insights spread across 213 pages with 110 Market data tables and figures & charts from the report on the "Global Musculoskeletal Market Size, Share, and COVID-19 Impact Analysis, By Type (Rheumatoid Arthritis, Osteoarthritis, Osteoporosis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia, Others), By Type of Molecules (Biologics, Small Molecules), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033."
Buy Now Full Report: https://www.sphericalinsights.com/checkout/5099
The osteoarthritis segment is expected to hold the largest share of the musculoskeletal market during the anticipation timeframe.
Based on the type, the musculoskeletal market is categorized into rheumatoid arthritis, osteoarthritis, osteoporosis, psoriatic arthritis, ankylosing spondylitis, fibromyalgia, and others. Among these, the osteoarthritis segment is expected to hold the largest share of the musculoskeletal market during the anticipation timeframe. Osteoarthritis is a common chronic joint disease that impacts millions of individuals globally. It mostly affects the elderly, whose numbers are rising due to global aging trends, and is a major contributor to disability.
The biologics segment is expected to grow at the fastest CAGR during the anticipation timeframe.
Based on the type of molecules, the musculoskeletal market is categorized into biologics, and small molecules. Among these, the biologics segment is expected to grow at the fastest CAGR during the anticipation timeframe. Because of their complicated structure, biologics are difficult to detect and classify. Biologics are long-lasting and effective for treating psoriatic, rheumatoid, and other inflammatory arthritis patients. Additionally, biologics products are widely used in biopharmaceuticals for research and drug development, which helps to sustain the market's growth.
Inquire Before Buying This Research Report: https://www.sphericalinsights.com/inquiry-before-buying/5099
North America is projected to hold the largest share of the musculoskeletal market over the anticipation timeframe.
North America is projected to hold the largest share of the musculoskeletal market over the anticipation timeframe. The market in the area has potential due to the rising number of MSD cases brought on by obesity and unhealthy lifestyles, increased awareness, and better treatment choices. Overexertion injuries resulting from lifting, pushing, dragging, holding, carrying, or tossing an object cost business $13.4 billion annually, according to Liberty Mutual, the largest workers' compensation insurance provider in the country. Because these disorders are becoming more common, there is a growing market for musculoskeletal diseases.
Asia Pacific is expected to grow at the fastest CAGR growth of the musculoskeletal market during the anticipation timeframe. Conventional drugs and therapies like as acupuncture support the MSD market in countries like China, India, and Japan. The primary drivers of the sector are the aging of the global population, improvements in medical technology, and more public awareness. But problems like outrageous costs and regulatory barriers must be overcome in order to provide greater access and improved treatment outcomes.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the global market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. Major vendors in the Global Musculoskeletal Market are Zimmer Biomet Holdings, Inc., Stryker Corporation, Medtronic, Sanofi S.A, Bristol-Myers Squibb, Eli Lilly And Company, Mitsubishi Tanabe Pharma Corporation, EverEx, Horizon Therapeutics plc, Procter & Gamble, Eisai Co. Ltd and Other Key Vendors.
Get Discount At @ https://www.sphericalinsights.com/request-discount/5099
Recent Developments
- In July 2024, Stryker, a US-based medical device manufacturer, announced that it has effectively purchased Artelon, a soft tissue fixation company, to grow its surgical market share. The acquisition is expected to be valued at $3.4 billion.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global musculoskeletal market based on the below-mentioned segments:
Global Musculoskeletal Market, By Type
- Rheumatoid Arthritis
- Osteoarthritis
- Osteoporosis
- Psoriatic Arthritis
- Ankylosing Spondylitis
- Fibromyalgia
- Others
Global Musculoskeletal Market, By Type of Molecule
- Biologics
- Small Molecules
Global Musculoskeletal Market, By Regional
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
-
- US
- Canada
- Mexico
Browse Related Reports:
Global Contraceptive Drugs Market Size, Share, and COVID-19 Impact Analysis, By Product (Oral (Combined Contraceptives and Progestin-only Pills), Injectable, and Patches), By Distribution channels (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel and NGOs, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033
Global Oncology Based Molecular Diagnostics Market Size, Share, and COVID-19 Impact Analysis, By Product (Instruments, and Reagents), By Technology (Polymerase Chain Reaction, Chips & Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification), By Application (Breast Cancer, Prostate Cancer, Colorectal Cancer, Skin Cancer, Cervical Cancer), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033.
Global Healthcare Fraud Detection Market Size, Share, and COVID-19 Impact Analysis, By Type (Descriptive Analytics, Predictive Analytics, and Prescriptive Analytics), By Delivery Model (On-premises, Cloud-based, and Others), By Application (Insurance Claims Review, Pharmacy Billing Issues, Payment Integrity, and Others), By End User (Private Insurance Payers, Public and Government Agencies, Third Party Service Providers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033
Global Adaptive Stroller Market Size, Share, and COVID-19 Impact Analysis, By Type (Single Seats, Multiple Seats), By Application (Cerebral Palsy, Traumatic Brain Injury, Developmental Delay, Spinal Muscular Atrophy, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Follow Us: LinkedIn | Facebook | Twitter
